Generating conditional mouse mutants via tetracycline-controlled gene expression.
暂无分享,去创建一个
[1] G. Fishman,et al. Conditional lineage ablation to model human diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Tenen,et al. Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.
[3] B. Conklin,et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice , 1999, Nature Biotechnology.
[4] H. Bujard,et al. Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. , 2000, Methods in enzymology.
[5] R. Cortese,et al. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. , 2002, Human gene therapy.
[6] Studies on Conditional Gene Expression in the Brain , 1999, Annals of the New York Academy of Sciences.
[7] Eric R. Kandel,et al. Inducible and Reversible Enhancement of Learning, Memory, and Long-Term Potentiation by Genetic Inhibition of Calcineurin , 2001, Cell.
[8] R. Flavell,et al. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. , 1997, The Journal of clinical investigation.
[9] Andrey Rzhetsky,et al. A Chemosensory Gene Family Encoding Candidate Gustatory and Olfactory Receptors in Drosophila , 2001, Cell.
[10] M. Gossen,et al. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.
[11] J. Mallet,et al. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors , 1999, Nature Biotechnology.
[12] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] René Hen,et al. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .
[14] D. Kioussis,et al. Inducible expression of a p56Lck transgene reveals a central role for Lck in the differentiation of CD4 SP thymocytes. , 2000, Immunity.
[15] W. Hillen,et al. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. , 1994, Annual review of microbiology.
[16] J. Vilotte,et al. Use of doxycycline-controlled gene expression to reversibly alter milk-protein composition in transgenic mice. , 2001, European journal of biochemistry.
[17] E. Kandel,et al. Inducible and Reversible Gene Expression with the rtTA System for the Study of Memory , 1998, Neuron.
[18] C Benoist,et al. Tetracycline-controllable selection of CD4(+) T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules. , 2000, The Journal of experimental medicine.
[19] M. Wilkinson,et al. The stability and fate of a spliced intron from vertebrate cells. , 1999, RNA.
[20] J. Chamberlain,et al. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. , 2000, Human molecular genetics.
[21] M. L. Kaplan,et al. Tetracycline-regulated cardiac gene expression in vivo. , 1994, The Journal of clinical investigation.
[22] David K. Stevenson,et al. Bioluminescent indicators in living mammals , 1998, Nature Medicine.
[23] S. Prusiner,et al. Doxycycline control of prion protein transgene expression modulates prion disease in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Gossen,et al. Tetracyclines in the control of gene expression in eukaryotes , 2001 .
[25] L. Tsui,et al. Regulated expression of the human CFTR gene in epithelial cells. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] M. Gossen,et al. Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. , 1997, Methods in enzymology.
[27] S. Tilghman,et al. The temporal requirement for endothelin receptor-B signalling during neural crest development , 1999, Nature.
[28] M. Gossen,et al. Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.
[29] Eric R Kandel,et al. Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.
[30] G. Fishman,et al. Regulated expression of foreign genes in vivo after germline transfer. , 1994, The Journal of clinical investigation.
[31] G. Fishman,et al. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.
[32] A. Poole,et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.
[33] Hermann Bujard,et al. Tetracycline-regulated gene expression in the brain , 2000, Current Opinion in Neurobiology.
[34] E. Kandel,et al. Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.
[35] M. T. Hasan,et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Benoist,et al. Role of the forkhead transcription family member, FKHR, in thymocyte differentiation , 2000, European journal of immunology.
[37] H. Bujard,et al. The B Lymphocyte-Specific Coactivator BOB.1/OBF.1 Is Required at Multiple Stages of B-Cell Development , 2001, Molecular and Cellular Biology.
[38] W. Lee,et al. The retinoblastoma gene regulates somatic growth during mouse development. , 2001, Cancer research.
[39] J. Tichelaar,et al. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[40] L. Hennighausen,et al. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system , 1995, Journal of Cellular Biochemistry.
[41] M. Gossen,et al. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. , 1997, Nucleic acids research.
[42] A. Glick,et al. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. , 2000, The Journal of investigative dermatology.
[43] R. Homer,et al. Use of the Tetracycline-controlled Transcriptional Silencer (tTS) to Eliminate Transgene Leak in Inducible Overexpression Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[44] René Hen,et al. Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.
[45] J. Tichelaar,et al. Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.
[46] D. Bohl,et al. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts , 1997, Nature Medicine.
[47] M. Kelz,et al. Transgenic animals with inducible, targeted gene expression in brain. , 1998, Molecular pharmacology.
[48] J. Perea,et al. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. , 2001, Human molecular genetics.
[49] D. Surmeier,et al. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine , 1999, Nature.
[50] D. Felsher,et al. Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.
[51] Mark Ptashne,et al. Negative effect of the transcriptional activator GAL4 , 1988, Nature.
[52] S. Efrat,et al. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Sarao,et al. Conditional Transgene Expression in Endothelial Cells , 1998, Transgenic Research.
[54] M. Husain,et al. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[55] A. P. Soler,et al. Conversion of C57Bl/6 mice from a tumor promotion–resistant to a –sensitive phenotype by enhanced ornithine decarboxylase expression , 1999, Molecular carcinogenesis.
[56] T. Liang,et al. Conditional Liver-specific Expression of Simian Virus 40 T Antigen Leads to Regulatable Development of Hepatic Neoplasm in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[57] U. Schibler,et al. The 5' flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. , 1994, Nucleic acids research.
[58] M. Mayford,et al. A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse. , 2001, Nucleic acids research.